2024 Rome, Italy

III-095 François Riglet
Successful Establishment of Optimal Biological Dose (OBD) through PK/PD Modeling of BCL2/BIM Complex Disruption in Clinical Trials using a BCL-2 Inhibitor.
Thursday 09:50-11:20